What were Amanta Healthcare Ltd's latest quarterly results?
Amanta Healthcare Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +8.2%
- Revenue Growth YoY: +9.9%
- Operating Margin: 20.6%
Amanta Healthcare Ltd: Stock Analysis & Fundamentals
Data from 2w agoAmanta Healthcare Ltd (Pharmaceuticals Bulk Drugs & Formulation) — fundamental analysis, earnings data, and key metrics. PE: 31.5. ROE: 13.0%. This stock is not currently in the Nifty 500 momentum outperformers list.
Amanta Healthcare Ltd Key Facts
What's Happening
🏛️DII reducing — stake down 1.5%
Key Numbers
Current Price
₹129
Market Cap
503 Cr
Valuation
N/AOther Top Pharmaceuticals Bulk Drugs & Formulation Stocks Beating Nifty 500
Frequently Asked Questions: Amanta Healthcare Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Amanta Healthcare Ltd's current PE ratio?
Amanta Healthcare Ltd's current PE ratio is 31.5x.
- Current PE: 31.5x
- Market Cap: 503 Cr
What is Amanta Healthcare Ltd's price-to-book ratio?
Amanta Healthcare Ltd's price-to-book ratio is 2.4x.
- Price-to-Book (P/B): 2.4x
- Book Value per Share: ₹54
- Current Price: ₹129
Is Amanta Healthcare Ltd a fundamentally strong company?
Amanta Healthcare Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 15.0%
Is Amanta Healthcare Ltd debt free?
Amanta Healthcare Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹186 Cr
What is Amanta Healthcare Ltd's return on equity (ROE) and ROCE?
Amanta Healthcare Ltd's return ratios over recent years
- FY2023: ROCE 13.0%
- FY2024: ROCE 14.0%
- FY2025: ROCE 15.0%
Is Amanta Healthcare Ltd's cash flow positive?
Amanta Healthcare Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹47 Cr
- Free Cash Flow (FCF): ₹23 Cr
- CFO/PAT Ratio: 470% (strong cash conversion)
What is Amanta Healthcare Ltd's dividend yield?
Amanta Healthcare Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹129
Who holds Amanta Healthcare Ltd shares — promoters, FII, DII?
Amanta Healthcare Ltd's shareholding pattern (Mar 2026)
- Promoters: 63.7%
- FII (Foreign): 0.8%
- DII (Domestic): 12.9%
- Public: 22.6%
Is promoter holding increasing or decreasing in Amanta Healthcare Ltd?
Amanta Healthcare Ltd's promoter holding has increased recently.
- Current Promoter Holding: 63.7% (Mar 2026)
- Previous Quarter: 63.6% (Dec 2025)
- Change: +0.16% (increasing — positive signal)
Is Amanta Healthcare Ltd a new momentum entry or an established outperformer?
Amanta Healthcare Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Amanta Healthcare Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Amanta Healthcare Ltd may be worth studying
- Cash flow is positive — CFO ₹47 Cr
What is the investment thesis for Amanta Healthcare Ltd?
Amanta Healthcare Ltd investment thesis summary:
What is the future outlook for Amanta Healthcare Ltd?
Amanta Healthcare Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.